Phosphatidylinositol 3-kinase p110δ expression in Merkel cell carcinoma

The prognosis of stage III/IV Merkel cell carcinoma (MCC) is very poor. The Phosphatidylinositol 3-kinase p110δ specific inhibitor idelalisib has recently been reported to induce complete clinical remission in a stage IV MCC patient. Here we assessed the expression of p110δ in primary MCC and MCC ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Chteinberg, Emil, Rennspiess, Dorit, Sambo, Ryan, Tauchmann, Samantha, Kelleners-Smeets, Nicole W.J., Winnepenninckx, Véronique, Speel, Ernst-Jan, Kurz, Anna Kordelia, Zenke, Martin, zur Hausen, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049866/
https://www.ncbi.nlm.nih.gov/pubmed/30038704
http://dx.doi.org/10.18632/oncotarget.25619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049866/
https://www.ncbi.nlm.nih.gov/pubmed/30038704
http://dx.doi.org/10.18632/oncotarget.25619

Ejemplares similares